febuxostat has been researched along with Coronary Heart Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, Z; Li, M; Ma, G; Teng, W; Xia, Z; Zhai, X | 1 |
1 trial(s) available for febuxostat and Coronary Heart Disease
| Article | Year |
|---|---|
Febuxostat combined with hydration for the prevention of contrast-induced nephropathy in hyperuricemia patients undergoing percutaneous coronary intervention: A CONSORT-compliant randomized controlled trial.
Topics: Combined Modality Therapy; Contrast Media; Coronary Angiography; Coronary Disease; Creatinine; Febuxostat; Fluid Therapy; Glomerular Filtration Rate; Gout Suppressants; Humans; Hyperuricemia; Kidney Diseases; Lipocalin-2; Percutaneous Coronary Intervention; Treatment Outcome; Uric Acid | 2022 |